Clinical trial
Treatment of Acute Lymphoblastic Leukemia in Children
NCT00400946 is registered in ClinicalTrials.gov with Dana-Farber Cancer Institute as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Treatment of Acute Lymphoblastic Leukemia in Children
- Lead sponsor
- Dana-Farber Cancer Institute
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- April 30, 2005
- Completion date
- June 30, 2019
- Enrollment
- 800 (actual)
- Sites
- 8
Conditions
As the registry lists them; a condition with its own page is linked.
drug/agent toxicity by tissue/organ, leukemia